HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heino, J. Articles by Massague, J. Search for Related Content PubMed PubMed Citation Articles by Heino, J. Articles by Massague, J. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 18, 10181-10184, Jun, 1990

Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta

J Heino and J Massague
Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Transforming growth factor beta 1 (TGF-beta 1) is an inhibitor of skeletal muscle myoblast differentiation. Myoblast differentiation is dependent on the expression of certain myogenic differentiation genes and is affected by cell interaction with the extracellular matrix. We have searched for events in the differentiation process of L6E9 rat myoblasts that may be involved in the inhibitory action of TGF-beta 1. Elevated expression of the myogenic differentiation gene, myogenin, which is thought to play a central role in the differentiation process, occurs 10 h after the shift of L6E9 myoblasts to differentiation medium. Elevation of myogenin mRNA is blocked by TGF-beta 1 added at the time of the shift. This effect is preceded by, and might be related to, a rapid up-regulation of junB mRNA observed in TGF-beta 1-treated L6E9 myoblasts. However, TGF-beta 1 can also block myogenic differentiation in cells transfected with the myogenin gene under the control of a constitutive SV40 viral promoter. The nature of a mechanism that could mediate the inhibitory action of TGF-beta 1 without blocking myogenin mRNA expression is suggested by the observations that (a) TGF-beta 1 upregulates type I collagen expression and deposition in L6E9 myoblasts, (b) a fibrillar type I collagen layer inhibits L6E9 myoblast differentiation, and (c) inhibition of L6E9 myoblast differentiation by a type I collagen layer occurs without a block in myogenin expression. Thus, the data suggest that inhibition of L6E9 myoblast differentiation by TGF-beta 1 may be accomplished by at least two mechanisms acting in concert. One mechanism leads to a block in the expression of myogenin whereas the other mechanism may involve TGF-beta 1-induced changes in cell adhesion that either block the action of myogenic differentiation gene products or prevent the function of other as yet unknown components of the myogenic differentiation pathway.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				O. Scherner, S. K. Meurer, L. Tihaa, A. M. Gressner, and R. Weiskirchen Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-beta1 and BMP-7 Signaling J. Biol. Chem., May 11, 2007; 282(19): 13934 - 13943. [Abstract] [Full Text] [PDF]

				J. P. Henriquez, J. C. Casar, L. Fuentealba, D. J. Carey, and E. Brandan Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation J. Cell Sci., May 15, 2002; 115(10): 2041 - 2051. [Abstract] [Full Text] [PDF]

				S. Rousse, F. Lallemand, D. Montarras, C. Pinset, A. Mazars, C. Prunier, A. Atfi, and C. Dubois Transforming Growth Factor-beta Inhibition of Insulin-like Growth Factor-binding Protein-5 Synthesis in Skeletal Muscle Cells Involves a c-Jun N-terminal Kinase-dependent Pathway J. Biol. Chem., December 7, 2001; 276(50): 46961 - 46967. [Abstract] [Full Text] [PDF]

				D. Liu, B. L. Black, and R. Derynck TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3 Genes & Dev., November 15, 2001; 15(22): 2950 - 2966. [Abstract] [Full Text] [PDF]

				F. M. GREGOIRE, C. M. SMAS, and H. S. SUL Understanding Adipocyte Differentiation Physiol Rev, July 1, 1998; 78(3): 783 - 809. [Abstract] [Full Text] [PDF]

				M. Ichida, H. Endo, U. Ikeda, C. Matsuda, E. Ueno, K. Shimada, and Y. Kagawa MyoD Is Indispensable for Muscle-specific Alternative Splicing in Mouse Mitochondrial ATP Synthase gamma -Subunit Pre-mRNA J. Biol. Chem., April 3, 1998; 273(14): 8492 - 8501. [Abstract] [Full Text] [PDF]

				E. Chang and H. Goldberg Requirements for Transforming Growth Factor-beta Regulation of the Pro-alpha2(I) Collagen and Plasminogen Activator Inhibitor-1 Promoters J. Biol. Chem., March 3, 1995; 270(9): 4473 - 4477. [Abstract] [Full Text] [PDF]

				T. Riikonen, L. Koivisto, P. Vihinen, and J. Heino Transforming Growth Factor-beta Regulates Collagen Gel Contraction by Increasing alpha2beta1 Integrin Expression in Osteogenic Cells J. Biol. Chem., January 6, 1995; 270(1): 376 - 382. [Abstract] [Full Text] [PDF]

				E. Filvaroff, R Ebner, and R Derynck Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor Development, January 5, 1994; 120(5): 1085 - 1095. [Abstract] [PDF]

				S. B. Milam, C. Haskin, G. Zardeneta, Dali Chen, V. L. Magnuson, R. J. Klebe, and B. Steffenson Cell Adhesion Proteins in Oral Biology Critical Reviews in Oral Biology & Medicine, January 1, 1991; 2(4): 451 - 491. [Full Text] [PDF]